抗感染药物市场战略、顶级参与者、增长机会、2031 年分析和预测

  • Report Code : TIPRE00004201
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

抗感染药物市场规模预计将从 2023 年的 1399 亿美元增至 2031 年的 1768 亿美元。预计 2023-2031 年期间市场复合年增长率为 3.2%。药物输送系统的创新可能仍是市场的主要趋势。

抗感染药物市场分析

传染病发病率的上升推动了市场的增长。根据世界卫生组织 (WHO) 的数据,2022 年,全球有 1060 万人患结核病,高于 2021 年的 1030 万人和 2020 年的 1000 万人。同样,2022 年,世卫组织估计全球疟疾病例数将达到 2.49 亿。如此高的传染病发病率增加了对抗感染药物市场的需求。

抗感染药物市场概况

传染病发病率上升、耐药病原体出现增多、人口老龄化加剧、药物研发创新、政府举措和资金支持不断增加、医院内感染发病率上升、抗感染药物渠道强劲以及公众对传染病认识不断提高,这些都是推动抗感染药物市场增长的因素。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

抗感染药物市场:

抗感染药物市场
  • Anti-Infective Agents Market
    复合年增长率(2023 - 2031)
    3.2%
  • 2023 年市场规模
    1,399 亿美元
  • 2031 年市场规模
    1,768 亿美元

市场动态

增长动力
  • 目标疾病患病率上升
未来趋势
  • 新型抗感染药物的开发
机会
  • 政府加大对研究活动的支持

关键人物

  • 雅培
  • 艾尔建公司(Allergan Plc)
  • 安斯泰来制药公司
  • 默克公司
  • 拜耳公司
  • 百时美施贵宝公司
  • 勃林格殷格翰国际有限公司
  • F.霍夫曼-拉罗氏有限公司
  • 吉利德科学公司
  • 葛兰素史克公司

区域概况

Anti-Infective Agents Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Anti-Infective Agents Market类型
  • 抗病毒物质
  • 抗菌
  • 抗真菌
Anti-Infective Agents Market范围
  • 窄谱和宽谱
Anti-Infective Agents Market给药途径
  • 口服
  • 主题
Anti-Infective Agents Market指征
  • 艾滋病病毒
  • 结核
  • 呼吸道感染
  • 肺炎
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

抗感染药物市场驱动因素和机遇

耐药病原体增多,利好市场

抗生素耐药性病原体的增加增加了对新型抗感染药物的需求。根据美国疾病控制和预防中心的数据,在美国,每年发生超过 280 万例抗生素耐药性感染。同样,根据最新的国家监测数据,英国卫生安全局 (UKHSA) 年度会议估计,2022 年英格兰有 58,224 人患有抗生素耐药性感染,比 2021 年(55,792 人)增加了 4%。

政府支持和举措可能创造增长机会

政府机构对开发新型抗感染药物和分发抗感染药物的支持可能会有利于市场的增长。例如,印度政府将通过国家艾滋病和性病控制计划 (NACP),免费向全国各地治疗机构的艾滋病患者提供高质量的抗逆转录病毒 (ARV) 药物。

同样,为了终结艾滋病毒流行,美国政府投入了数十亿美元支持全国乃至全球的艾滋病毒检测、预防、治疗和研究计划。美国政府每年花费超过 280 亿美元支持“终结美国艾滋病毒流行”计划 (EHE) 的实施。

抗感染药物市场报告细分分析

有助于抗感染药物市场分析的关键部分是类型、范围、动物类型、疾病类型和最终用户。

  • 抗感染药物市场按类型分为抗菌、抗病毒、抗真菌和其他。抗病毒药物在 2022 年占据了最大的市场份额。预计抗病毒药物在预测期内将实现最高的复合年增长率。
  • 根据范围,全球抗感染药物市场分为广谱和窄谱。2023 年,窄谱部分占据了最大的市场份额。然而,预计在预测期内,广谱部分的需求将以最快的复合年增长率增长。
  • 根据给药途径,市场分为外用、口服、静脉注射和其他。2023 年,静脉注射部分占据了最大的市场份额。然而,预计在预测期内,外用部分的需求将以最快的复合年增长率增长。
  • 从适应症来看,全球抗感染药物市场分为艾滋病毒、结核病、呼吸道感染、肺炎等。2022 年,艾滋病毒领域可能占据最大的市场份额。此外,预计在预测期内,该领域的需求将以最快的复合年增长率增长。
  • 根据分销渠道,全球抗感染药物市场分为医院药房、专科药房、电子商务和其他。2022 年,医院药房部门可能占据最大的市场份额。然而,电子商务部门预计在预测期内将实现市场最高复合年增长率。

抗感染药物市场份额按地区分析

抗感染药物市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

北美抗感染药物市场已细分为美国、加拿大和墨西哥。产品获批数量不断增加、研发活动不断增加以及对治疗慢性病和病毒性疾病的先进治疗方案的需求不断增长是推动该地区市场增长的主要因素。

 由于老龄人口不断增加、慢性病毒性疾病患病率不断上升以及该地区对开发新型抗病毒药物的需求旺盛等因素,欧洲是第二大市场。2007 年至 2019 年,欧盟通过第七框架计划和“地平线 2020”计划获得了 157.9 亿美元的资助,此外还承诺为冠状病毒研究提供 11 亿美元资金,欧盟在资助和协调传染病研究方面发挥着至关重要的作用。

抗感染药物市场报告范围

报告属性细节
2023 年的市场规模1399亿美元
2031 年市场规模1768亿美元
全球复合年增长率(2023 - 2031)3.2%
史料2021-2022
预测期2024-2031
涵盖的领域按类型
  • 抗病毒物质
  • 抗菌
  • 抗真菌
按范围
  • 窄谱和宽谱
按给药途径
  • 口服
  • 主题
按适应症
  • 艾滋病病毒
  • 结核
  • 呼吸道感染
  • 肺炎
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 雅培
  • 艾尔建公司(Allergan Plc)
  • 安斯泰来制药公司
  • 默克公司
  • 拜耳公司
  • 百时美施贵宝公司
  • 勃林格殷格翰国际有限公司
  • F.霍夫曼-拉罗氏有限公司
  • 吉利德科学公司
  • 葛兰素史克公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

抗感染药物市场新闻和最新发展

抗感染剂市场通过收集一手和二手研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。抗感染剂市场的一些发展情况如下:

  • 诺华旗下 Sandoz 宣布延长与 Ares Genetics (Ares) 的合作协议,旨在推动全球抗击抗菌素耐药性 (AMR) 的尖端数字解决方案。(来源:Sandoz,新闻稿/公司网站/时事通讯,2022 年 4 月)
  • Orchid Pharma 已与 Cipla 合作,在印度各地分销其突破性的抗生素组合。(来源:Cipla,新闻稿/公司网站/时事通讯,2024 年 7 月)

抗感染药物市场报告范围和交付成果

“抗感染药物市场规模和预测(2021-2031 年)”报告对以下领域进行了详细的市场分析:

  • 抗感染药物市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 抗感染药物市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 抗感染药物市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及抗感染药物市场的最新发展
  • 详细的公司简介
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the anti-infective agents market?

The anti-infective agents market is estimated to grow with a CAGR of 3.2% from 2023 to 2031.

What would be the estimated value of the anti-infective agents market by 2031?

The estimated value of the anti-infective agents market by 2031 is US$ 176.8 billion billion

Which are the leading players operating in the anti-infective agents market?

The anti-infectives agents market majorly consists of the players such as Abbott, Allergan Plc., Astellas Pharma Inc., Merck & Co., Inc., Bayer AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, F. HOFFMANN-LA ROCHE Ltd., Gilead Sciences, Inc., GlaxoSmithKline plc., Novartis AG among others.

What are the future trends of the anti-infective agents market Market?

Rising Investments in R&D Activities in Pharmaceutical Sector

What are the driving factors impacting the anti-infective agents market Market?

The market drivers include rising prevalence of targeted diseases and rising government support for research activities and clinical trials are leading to increasing usage of anti-infectives agents market. However, emergence of anti-infective drugs resistance and their side effects is a key restraining factor for the market growth.

Which region dominated the anti-infective agents market Market in 2023?

North America dominated the anti-infective agents market in 2023

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.